Professor | Yongping Ma | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yongping Ma
Contact Information	ypma99@163.com
Language ability	Chinese, English
Province	Chongqing

Upload Avatar (500 x 500)

Name

Yongping Ma

Contact Information

ypma99@163.com

Language ability

Chinese, English

Province

Chongqing

University/Lab Affiliation and Title	Chongqing Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2002.09-2005.06 Doctor of Medicine: Chongqing Medical University 1997.09-2000.06 Master of Science in Microbiology: Wuhan University 1986.09-1989.07 Diploma in Biology: Tianshui Normal School First Chongqing Young and Middle-aged Backbone Teacher Leader in Biochemistry and Molecular Biology in Chongqing China Industry-University-Research Cooperation Innovation Award (Individual)
Work Experience	2010.04-present - Chongqing Medical University, PI at Molecular Medicine and Oncology Research Center 2009.04-2010.04 - Visiting Scholar at NIAID, NIH (USA) 2005.06-2009.03 - Deputy Director, Associate Professor, Professor at Chongqing Medical University 2000.07-2002.08 - Lecturer at Chongqing Medical University 1989.07-1995.08 - Teacher at Gansu Province Dangchang County Shawan Middle School
Awards	2002: Second Prize for Scientific and Technological Progress, China University Science and Technology Awards Committee 2004: Chongqing Young and Middle-aged Backbone Teacher Title 2008: Reserve Candidate for Academic and Technical Leader in Biochemistry and Molecular Biology, Chongqing 2009: Third Prize for Scientific and Technological Progress in Chongqing 2009: Second Prize for Higher Education Teaching Achievements in Chongqing 2020: China Industry-University-Research Promotion Association Innovation Award (Individual)

University/Lab Affiliation and Title

Chongqing Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2002.09-2005.06 Doctor of Medicine: Chongqing Medical University
1997.09-2000.06 Master of Science in Microbiology: Wuhan University
1986.09-1989.07 Diploma in Biology: Tianshui Normal School
First Chongqing Young and Middle-aged Backbone Teacher
Leader in Biochemistry and Molecular Biology in Chongqing
China Industry-University-Research Cooperation Innovation Award (Individual)

Work Experience

2010.04-present - Chongqing Medical University, PI at Molecular Medicine and Oncology Research Center
2009.04-2010.04 - Visiting Scholar at NIAID, NIH (USA)
2005.06-2009.03 - Deputy Director, Associate Professor, Professor at Chongqing Medical University
2000.07-2002.08 - Lecturer at Chongqing Medical University
1989.07-1995.08 - Teacher at Gansu Province Dangchang County Shawan Middle School

Awards

2002: Second Prize for Scientific and Technological Progress, China University Science and Technology Awards Committee
2004: Chongqing Young and Middle-aged Backbone Teacher Title
2008: Reserve Candidate for Academic and Technical Leader in Biochemistry and Molecular Biology, Chongqing
2009: Third Prize for Scientific and Technological Progress in Chongqing
2009: Second Prize for Higher Education Teaching Achievements in Chongqing
2020: China Industry-University-Research Promotion Association Innovation Award (Individual)

Areas of Focus	Tumor Targeted Therapy Immunology
Publications	Deciphering the rule of antigen-antibody amino acid interaction., Jiang M#, Fang C#, Ma Y., 2023 Bifidobacterium infantis-Mediated Herpes Simplex Virus-TK/Ganciclovir Treatment Inhibits Cancer Metastasis in Mouse Model., Wang C#, Shen Y#, Ma Y., 2023 Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis., Fang C, Ma Y., 2023 Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer., Jiang M#, Fang C#, Ma Y., 2023 Ultrasensitive electrochemical biosensor for des-gamma-carboxy prothrombin analysis based on core-shell Pd@PtCu-alloy loaded on WS2 nanosheet., Xuhuai Fu, Xinmin Li, Daobin Han, Wei Yang, Changjin Liu, Lu Fan, Shijia Ding, Yongping Ma., 2021 Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1., Liu L, Ma Y, Zhou H, Wu M., 2016 Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors., Wang C, Ma Y, Hu Q, Xie T, Wu J, Zeng F, Song F., 2016 Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir., Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y., 2016 Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants., Ma Y., 2016 Identification of G and P genotype-specific motifs in the predicted VP7 and VP4 amino acid sequences., Ma Y., 2015 Cloning and nucleotide sequence analyses of 11 genome segments of two American and one British equine rotavirus strains., Ma Y, Wen X, Hoshino Y, Yuan L., 2015 Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli., Ma Y, Luo Y, Huang X, Song F, Liu G., 2012

Areas of Focus

Tumor Targeted Therapy
Immunology

Publications

Deciphering the rule of antigen-antibody amino acid interaction., Jiang M#, Fang C#, Ma Y*., 2023
Bifidobacterium infantis-Mediated Herpes Simplex Virus-TK/Ganciclovir Treatment Inhibits Cancer Metastasis in Mouse Model., Wang C#, Shen Y#, Ma Y*., 2023
Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis., Fang C, Ma Y*., 2023
Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer., Jiang M#, Fang C#, Ma Y*., 2023
Ultrasensitive electrochemical biosensor for des-gamma-carboxy prothrombin analysis based on core-shell Pd@PtCu-alloy loaded on WS2 nanosheet., Xuhuai Fu, Xinmin Li, Daobin Han, Wei Yang, Changjin Liu, Lu Fan, Shijia Ding, Yongping Ma*., 2021
Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1., Liu L, Ma Y*, Zhou H, Wu M., 2016
Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors., Wang C, Ma Y*, Hu Q, Xie T, Wu J, Zeng F, Song F., 2016
Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir., Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y*., 2016
Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants., Ma Y*., 2016
Identification of G and P genotype-specific motifs in the predicted VP7 and VP4 amino acid sequences., Ma Y*., 2015
Cloning and nucleotide sequence analyses of 11 genome segments of two American and one British equine rotavirus strains., Ma Y*, Wen X, Hoshino Y, Yuan L., 2015
Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli., Ma Y*, Luo Y, Huang X, Song F, Liu G., 2012

Cancer Therapy Targeted Treatment Tumor Immunology Antibody Gene Vaccine Biochemistry

Huirong Liu - Capital Medical University

Ling Chen - Guangzhou Medical University

Wei Gao - Nanjing Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us